Acacia Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 23-12-2024
- Paid Up Capital ₹ 0.10 M
as on 23-12-2024
- Company Age 23 Year, 7 Months
- Last Filing with ROC 31 Mar 2015
- Open Charges ₹ 1.70 M
as on 23-12-2024
- Revenue 9.71%
(FY 2015)
- Profit 70.36%
(FY 2015)
- Ebitda 42.11%
(FY 2015)
- Net Worth 24.31%
(FY 2015)
- Total Assets 95.80%
(FY 2015)
About Acacia Pharmaceuticals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2015. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.70 M.
Upasna Vir and Anoop Vir serve as directors at the Company.
- CIN/LLPIN
U24231JK2001PTC002159
- Company No.
002159
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jun 2001
- Date of AGM
30 Sep 2015
- Date of Balance Sheet
31 Mar 2015
- Listing Status
Unlisted
- ROC Code
Roc Jammu
Industry
Company Details
- LocationJammu And Kashmir, Jammu & Kashmir
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Acacia Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Upasna Vir  | Director | 12-Jun-2001 | Current |
| Anoop Vir | Director | 12-Jun-2001 | Current |
Financial Performance of Acacia Pharmaceuticals.
Acacia Pharmaceuticals Private Limited, for the financial year ended 2015, experienced modest growth in revenue, with a 9.71% increase. The company also saw a substantial improvement in profitability, with a 70.36% increase in profit. The company's net worth Soared by an impressive increase of 24.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Acacia Pharmaceuticals?
In 2015, Acacia Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Jammu Aand Kashmir Bank Limited Creation Date: 04 Sep 2015 | ₹1.40 M | Open |
Allahabad Bank Creation Date: 01 Dec 2004 | ₹0.30 M | Open |
How Many Employees Work at Acacia Pharmaceuticals?
Unlock and access historical data on people associated with Acacia Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Acacia Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acacia Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
